Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Health

Health Matters :


Print article Print article
Refer this article Refer to a friend
2009-11-13 14:41:08 -

www.medicarefinance.com

Episodes of pain may occur in the back of the head and upper neck. When these are related to tenderness or inflammation of the nerves supplying this area, the greater and lesser occipital nerves, the condition of occipital neuralgia may occur.

Causes of Occipital Neuralgia


Irritation of the occipital nerves may occur as the nerve emerges from underneath the neck muscles. These

same nerves may also be compressed at their origin in the neck, most commonly the C2 nerve roots.

Signs and Symptoms of Occipital Neuralgia


Occipital neuralgia produces pain in the back of the head. It may radiate forward or into the neck. Although the pain is episodic, it may last for extended periods of time.


Treatment is usually a mix of the following approaches:

1. Anti-inflammatory medicines
* Indomethacin
* Diclofenac
* Ibuprofen
* Cox-II inhibitors
2. Anti-convulsants
* Gabapentin
* Pregabalin
* Carbamazepine (Tegretol)
3. Nerve block injection

A nerve block usually consists of a mix of 40-80 mg of methylprednisolone and lidocaine or bupivicaine which is injected around the entry points of the greater occipital nerves. Local hair loss is the only commonly reported side-effect (about 2% risk). If the person with occipital neuralgia symptoms has diabetes, their blood sugar may increase in the week following methylprednisolone injection.

www.medicarefinance.com





Press Information:
Medicare Finance

Suite 241

Contact Person:
Vicky Winnick
Health Adviser
Phone: 3037676660
email: email

Web: www.medicarefinance.com

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.


Terms & Conditions | Privacy | About us | Contact PR-inside.com